Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$56.7K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
2 of 10 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 39 business days late.
The 22 most recent Form 4 transactions.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| Oct 14 | AKTX | Akari Therapeutics Plc | MEXER | 7,733 | $0.0004 | $3 | +23.1% | Open the original filing on SEC.gov |
| Oct 14 | AKTX | Akari Therapeutics Plc | MEXER | 19,333 | $0.0004 | $8 | +137.1% | Open the original filing on SEC.gov |
| Sep 29 | AKTX | Akari Therapeutics Plc | AGRANT | 6,430 | $9.72 | $62.5K | +83.8% | Open the original filing on SEC.gov |
| Aug 18 | AKTX | Akari Therapeutics Plc | AGRANT◆ | 174,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 24 | AKTX | Akari Therapeutics Plc | AGRANT◆ | 15,563 | — | — | — | Open the original filing on SEC.gov |
| Jun 24 | AKTX | Akari Therapeutics Plc | AGRANT◆ | 5,500 | — | — | — | Open the original filing on SEC.gov |
| Dec 16, 2025 | AKTX | Akari Therapeutics Plc | PDBUY◆ | 773,323 | $0.4041 | $312.5K | — | Open the original filing on SEC.gov |
| Dec 16, 2025 | AKTX | Akari Therapeutics Plc | PDBUY◆ | 773,323 | — | — | — | Open the original filing on SEC.gov |
| Dec 16, 2025 | AKTX | Akari Therapeutics Plc | PDBUY◆ | 309,328 | $0.4041 | $125K | — | Open the original filing on SEC.gov |
| Dec 16, 2025 | AKTX | Akari Therapeutics Plc | PDBUY◆ | 309,328 | — | — | — | Open the original filing on SEC.gov |
| Aug 25, 2025 | AKTX | Akari Therapeutics Plc | PBUY | 3,000 | $0.9 | $2.7K | +1.0% | Open the original filing on SEC.gov |
| Aug 22, 2025 | AKTX | Akari Therapeutics Plc | PBUY | 8,000 | $0.93 | $7.4K | +2.8% | Open the original filing on SEC.gov |
| Aug 21, 2025 | AKTX | Akari Therapeutics Plc | PBUY | 10,000 | $0.94 | $9.4K | +3.6% | Open the original filing on SEC.gov |
| Jun 24, 2025 | AKTX | Akari Therapeutics Plc | PBUY | 5,203 | $1.16 | $6K | +1.9% | Open the original filing on SEC.gov |
| Jun 23, 2025 | AKTX | Akari Therapeutics Plc | PBUY | 943 | $1.15 | $1.1K | +0.4% | Open the original filing on SEC.gov |
| Jun 20, 2025 | AKTX | Akari Therapeutics Plc | PBUY | 10,000 | $1.20 | $12K | +3.8% | Open the original filing on SEC.gov |
| Jun 17, 2025 | AKTX | Akari Therapeutics Plc | PBUY | 15,000 | $1.20 | $18K | +6.1% | Open the original filing on SEC.gov |
| Jun 13, 2025 | AKTX | Akari Therapeutics Plc | AGRANT | 25,000 | $1.19 | $29.8K | +11.3% | Open the original filing on SEC.gov |
| Jun 12, 2025 | AKTX | Akari Therapeutics Plc | AGRANT | 20,000 | $1.23 | $24.6K | +9.9% | Open the original filing on SEC.gov |
| Jun 10, 2025 | AKTX | Akari Therapeutics Plc | AGRANT | 20,000 | $1.27 | $25.4K | +11.0% | Open the original filing on SEC.gov |